NanoVibronix Statistics
Total Valuation
NanoVibronix has a market cap or net worth of $3.32 million. The enterprise value is $2.67 million.
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NanoVibronix has 759,297 shares outstanding. The number of shares has increased by 69.60% in one year.
| Current Share Class | 759,297 |
| Shares Outstanding | 759,297 |
| Shares Change (YoY) | +69.60% |
| Shares Change (QoQ) | +33.23% |
| Owned by Insiders (%) | 0.95% |
| Owned by Institutions (%) | 2.08% |
| Float | 630,726 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.46 |
| Forward PS | n/a |
| PB Ratio | 2.63 |
| P/TBV Ratio | 5.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.22, with a Debt / Equity ratio of 0.19.
| Current Ratio | 1.22 |
| Quick Ratio | 0.37 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -26.53 |
Financial Efficiency
Return on equity (ROE) is -160.56% and return on invested capital (ROIC) is -94.54%.
| Return on Equity (ROE) | -160.56% |
| Return on Assets (ROA) | -43.46% |
| Return on Invested Capital (ROIC) | -94.54% |
| Return on Capital Employed (ROCE) | -394.93% |
| Revenue Per Employee | $82,516 |
| Profits Per Employee | -$119,516 |
| Employee Count | 31 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 0.43 |
Taxes
In the past 12 months, NanoVibronix has paid $19,000 in taxes.
| Income Tax | 19,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.02% in the last 52 weeks. The beta is 2.00, so NanoVibronix's price volatility has been higher than the market average.
| Beta (5Y) | 2.00 |
| 52-Week Price Change | -46.02% |
| 50-Day Moving Average | 4.36 |
| 200-Day Moving Average | 5.99 |
| Relative Strength Index (RSI) | 46.32 |
| Average Volume (20 Days) | 6,216,561 |
Short Selling Information
The latest short interest is 110,124, so 14.50% of the outstanding shares have been sold short.
| Short Interest | 110,124 |
| Short Previous Month | 82,538 |
| Short % of Shares Out | 14.50% |
| Short % of Float | 17.46% |
| Short Ratio (days to cover) | 0.02 |
Income Statement
In the last 12 months, NanoVibronix had revenue of $2.56 million and -$3.71 million in losses. Loss per share was -$13.73.
| Revenue | 2.56M |
| Gross Profit | 1.51M |
| Operating Income | -3.58M |
| Pretax Income | -3.17M |
| Net Income | -3.71M |
| EBITDA | -3.58M |
| EBIT | -3.58M |
| Loss Per Share | -$13.73 |
Full Income StatementBalance Sheet
The company has $752,000 in cash and $116,000 in debt, giving a net cash position of $636,000 or $0.84 per share.
| Cash & Cash Equivalents | 752,000 |
| Total Debt | 116,000 |
| Net Cash | 636,000 |
| Net Cash Per Share | $0.84 |
| Equity (Book Value) | 627,000 |
| Book Value Per Share | 1.65 |
| Working Capital | 609,000 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$2.52 million and capital expenditures -$3,000, giving a free cash flow of -$2.52 million.
| Operating Cash Flow | -2.52M |
| Capital Expenditures | -3,000 |
| Free Cash Flow | -2.52M |
| FCF Per Share | -$3.32 |
Full Cash Flow StatementMargins
Gross margin is 58.95%, with operating and profit margins of -140.03% and -144.84%.
| Gross Margin | 58.95% |
| Operating Margin | -140.03% |
| Pretax Margin | -144.10% |
| Profit Margin | -144.84% |
| EBITDA Margin | -139.99% |
| EBIT Margin | -140.03% |
| FCF Margin | n/a |